A 48-year-old paralyzed patient from New York received a four-centimeter chip that will allow him to telepathically control digital devices.
Mount Sinai Medical Center in New York City hosted the first implantation of a permanent brain-machine interface to a metropolitan resident who suffers from amyotrophic lateral sclerosis (ALS) and is paralyzed.
This implant was developed by Synchron, which is a competitor to Neuralink and, according to experts, is already ahead of brain implants from Elon Musk. With the help of a new implant, which is created in the form of a standron (a set of wires and electrodes on a frame), the patient will be able to telepathically control digital devices. This operation was carried out without damaging the skull and head tissues.
The surgeon Shahram Majidi, who performed the operation, said that such an introduction of a brain chip is an important step for all medicine and this technology has great potential. According to the surgeon, the operation was successful, and the patient returned home two days later.
During the operation, the surgeon made an incision on the patient's neck and inserted the implant through the jugular vein into a blood vessel located in motor cortex, which is part of the frontal lobe of the brain.
This brain-computer interface has 16 electrodes that monitor brain activity and register neuronal activity when a person thinks about something. This implant is connected to another device implanted in the patient's chest. Thanks to new technology, a person will be able to transmit signals from the brain to digital devices such as a computer or smartphone and thus control them. Focus has already written about this technology from Synchron and how it works.
According to Tom Oxley, the founder of Synchron, now a person will be able to send text messages, e-mails and do online -shopping, which in turn will make his life a little easier.
“We have created technology that will help millions of people who have lost the ability to use their hands to control digital devices,” says Oxley.
Before this operation, Synchron had already tested its implants on four patients in Australia, who were able to control digital devices. With the successful introduction of a brain implant, Synchron takes the lead in the race against Neuralink. Elon Musk's company has so far only successfully introduced computer chips to a pig and a monkey. But according to Musk, Neuralink is working on a much more powerful chip, which will be much smaller than the Synchron.
According to Oxley, their technology can be used in the future to treat and diagnose Parkinson's disease, epilepsy, depression and hypertension.
Focus already wrote that a brain implant for the first time helped a patient from the UK to get rid of the symptoms of Parkinson's disease.